InterCure Ltd
TASE:INCR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
444
1 254
|
Price Target |
|
We'll email you a reminder when the closing price reaches ILS.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
InterCure Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | IL |
Market Cap | 239.6m ILS |
Operating Margin |
10%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Operating Margin |
-83%
|
Country | US |
Market Cap | 710.5B USD |
Operating Margin |
35%
|
Country | UK |
Market Cap | 440.4B GBP |
Operating Margin |
3%
|
Country | DK |
Market Cap | 3.3T DKK |
Operating Margin |
44%
|
Country | US |
Market Cap | 373.5B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 251.1B USD |
Operating Margin |
34%
|
Country | CH |
Market Cap | 202.7B CHF |
Operating Margin |
32%
|
Country | CH |
Market Cap | 183.3B CHF |
Operating Margin |
31%
|
Country | UK |
Market Cap | 162.4B GBP |
Operating Margin |
21%
|
Country | IE |
Market Cap | 146B USD |
Operating Margin |
11%
|
InterCure Ltd
Glance View
InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on InterCure Ltd's most recent financial statements, the company has Operating Margin of 9.6%.